Physician profile
Mitra Davis
NPI 1164574844
$6,183.79
in general payments reported to CMS, 2019-2025
20 companies · $379 in 2025
The $379 reported for 2025 was more than what 92% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $882 · 2022: $820 · 2023: $1,514 · 2024: $2,588 · 2025: $379.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,338 · Food and Beverage: $1,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,337.50 |
| Food and Beverage | $1,144.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $3,678.21 | 2022-2025 | Nexplanon |
| Abbvie INC. | $809.95 | 2021-2023 | |
| Evofem Biosciences, INC. | $452.81 | 2022-2025 | Phexxi, Solosec, Phexx |
| Mayne Pharma Commercial LLC | $305.70 | 2021-2025 | |
| Therapeuticsmd, INC. | $174.82 | 2021-2022 | |
| Astellas Pharma US INC | $130.30 | 2023-2025 | Veozah |
| Agile Therapeutics, INC. | $122.20 | 2021-2023 | Twirla |
| Sumitomo Pharma America, INC. | $85.84 | 2023-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $62.99 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.62 | 2021-2023 | |
| Coopersurgical, INC. | $54.61 | 2023-2024 | Wallach Cryosurgical Equipment, Fisherbrand Disposable Liquid Infant Heel Warmer |
| Exeltis, USA INC. | $43.56 | 2024-2025 | Slynd |
| Phadia US INC. | $42.37 | 2022 | |
| Myovant Sciences INC. | $30.32 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $28.87 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $26.86 | 2024 | Zurzuvae |
| Scynexis, INC. | $24.79 | 2022 | |
| Daiichi Sankyo INC. | $21.20 | 2022 | |
| Optumhealth Care Solutions, LLC | $16.31 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Millicent US INC | $14.46 | 2024 | Intrarosa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitra Davis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.